Table 1 Characteristics of lung cancer patients according to histological subtype

From: IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer

Characteristic

Adenocarcinoma, n=86

Squamous cell carcinoma, n=89

Age, years, median (range)

65.7 (42.5–82.7)

66.0 (41.4–86.2)

Sex, n (%)

 Male

46 (53.5)

63 (70.8)

 Female

40 (46.5)

26 (29.2)

Tumor stage, n (%)

 I

49 (57.0)

46 (51.7)

 II

14 (16.3)

26 (29.2)

 III

23 (26.7)

17 (19.1)

Tumor grade, n (%)

 I

9 (10.5)

2 (2.2)

 II

51 (59.3)

55 (61.8)

 III

26 (30.2)

32 (36.0)

Tumor size, cm, median (range)

3.8 (1–14)

4.0 (0.9–16)

Smoking status

 Current

26 (30.2)

26 (29.2)

 Former

53 (61.6)

60 (67.4)

 Never

7 (8.1)

3 (3.4)

Surgery type, n (%)

 Lobectomy

69 (80.2)

60 (67.4)

 Bilobectomy

10 (11.6)

4 (4.5)

 Pneumonectomy

7 (8.1)

25 (28.1)

Vital status by end of follow-up, n (%)

 Alive

35 (40.7)

37 (41.6)

 Dead

51 (59.3)

52 (58.4)